| Indication | Patent Group | Description | Countries |
|---|---|---|---|
| Cancer | ALL-ALA | This case relates to αLactalbumin complexes that have been engineered to optimize production | DE, DK, FI, FR, UK, NL, SE, AU, CA, IN, JP, USA |
| Cancer | Alpha1 and Alpha2 fragment complexes | This case relates to the αLA fragment complexes – comprising the human Alpha1 or Alpha2 sequences. | CH, DE, DK, ES, FI, FR, UK, HU, IE, IT, NL, NO, PL, SE USA USA divisional |
| Cancer | PAPILLOMA | This case relates to αLA complexes (including HAMLET and BAMLET) for treatment of skin papillomas. | USA USA divisional |
| Cancer | PROPHYLACTIC THERAPY | This case relates to αLA complexes for prophylactic treatment of cancer. | CH, DE, DK, ES, FI, FR, UK, HU, IE, IT, NL, NO, PL, SE, US divisional |
| Cancer | NUTRACEUTICAL | This case relates to milk-based nutraceuticals that contain αLA-complexes. | CH, DE, DK, ES, FI, FR, UK, IE, IT, NL, NO, SE, USA, HK |
| Cancer | 39-MER COMPLEX | This case relates to milk-based nutraceuticals | CH, DE, DK, ES, FI, FR, UK, IE, IT, NL, NO, PL, SE, HK, AU, CA, CN, IN, JP, KP, SG, USA |
| Cancer | MIXING METHOD | This case relates to a simplified production method. | Europe divisional Hong Kong USA continuation |
| Cancer | SYNERGISTIC COMBINATION CANCER THERAPY | This case relates to anticancer protein-fatty acid complexes plus other chemotherapeutic agents as a combination for use in anticancer therapy. | Europe USA Japan |
| Indication | Patent Group | Description | Countries |
|---|---|---|---|
| Infection /Immunotherapy | IL-1 RECEPTOR ANTAGONISTS | IL-1 receptor antagonists for the treatment of cystitis. | Australia Europe (CH, DE, DK, FI, FR, NL, SE, GB) USA |
| Infection /Immunotherapy | MMP7 INHIBITORS | MMP-7 inhibitors for the treatment of cystitis. | Australia Europe (CH, DE, DK, FI, FR, NL, SE, GB) |
| Infection /Immunotherapy | ASC / NLRP-3 | ASC or NLRP-3 proteins for the treatment of cystitis. | Europe USA |
| Infection /Immunotherapy | IRF7 INHIBITORS | IRF-7 inhibitors for the treatment of Enterobacteriaceae infections. | Australia Europe (CH, DE, DK, FI, FR, NL, SE, GB) USA |
| Infection /Immunotherapy | NK1 ANTAGONISTS | NK1 antagonists for treating bacterial infection or management of pain caused by bacterial infections. | Europe Hong Kong USA |
| Infection /Immunotherapy | POL II INHIBITORS | Inhibitors of polymerase II, which can be used for immunosuppression, anti-inflammation, and/or anti-infection. | Australia Europe (CH, DE, DK, FI, FR, NL, SE, GB) Hong Kong India Singapore USA |
| Infection /Immunotherapy | BLADDER PAIN | IL-1 receptor antagonists for the treatment of bladder pain. | Europe USA Australia China Japan |
| Infection /Immunotherapy | PYELONEPHRITIS | Treatment or prevention of acute pyelonephritis and/or urosepsis. | Geat Britain, initial filing |
| Indication | Patent Group | Description | Countries |
|---|---|---|---|
| Tuberculosis | TUBERCULOSIS TREATMENT | Bactericidal peptide Plectasin for the treatment of M. tuberculosis. | CH, DE, DK, FI, FR, NL, SE, UK, AU, CA, HK, IN, USA |